COVID & HBOT
Potential benefits of Hyperbaric Oxygen Therapy (HBOT) in the treatment of Long COVID may include improved oxygenation of hypoxic tissues, a reduction in inflammatory cytokine production
COVID & HYPERBARICS
Coronavirus disease (COVID-19) is an infectious illness caused by the SARS-CoV-2 virus, a novel strain of coronavirus identified in 2019. In March 2020, the World Health Organization officially declared the outbreak a global pandemic. COVID-19 primarily affects the respiratory system and presents with a wide range of symptoms, from mild to severe. In some cases, individuals may remain asymptomatic yet still be capable of transmitting the virus to others.
Potential benefits of Hyperbaric Oxygen Therapy (HBOT) in the treatment of Long COVID may include improved oxygenation of hypoxic tissues, a reduction in inflammatory cytokine production, and enhanced mobilization of hematopoietic stem cells—precursors to red blood cells, white blood cells, and platelets.
HOW HBOT CAN HELP
General Benefits
-
General Condition Reversal
-
Improved Liver Function
-
Improved Myocardial Injury
-
Decreases Systemic Inflammation
-
Decreased Chest Pain
Pulmonary Benefits
-
Rapid Relief of Hypoxic Symptoms
-
Decreased Dyspnea (difficulty breathing)
-
Improved Lung Pathology
-
Increases Blood Oxygen Saturation
-
Shown to be Safe During Mechanical Ventilation
-
Decrease in Pulmonary Inflammation
-
Gradual Improvement of Arterial Blood Gas
Long-Haul COVID
Post-COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-Co-V-2 infection, usually 3 months from the onset of COVID-19 that last for at least 2 months and cannot be explained by an alternative diagnosis.
Common symptoms of long-COVID include fatigue, shortness of breath, cough, joint pain, chest pain, memory and concentration difficulties, sleep problems, muscle pain, fast or pounding heartbeat, loss of smell or taste, anxiety and depression, dizziness when standing, and worsened symptoms after physical or mental exertion.
Hyperbarics for Long-Haul COVID
-
Decreased Dyspnea (difficulty breathing)
-
Decreased Fatigue Levels
-
Improved Verbal Function
-
Improves Lung Capacity & Exercise Tolerance
-
Improved Executive Function
-
Improved Global Cognition
-
Increased Attention Span
-
Increased Information Processing Speed
Dr. Jason Sonners of HBOT USA discusses the benefits of HBOT with Covid.
REFERENCES
-
Paul G. Harch. Hyperbaric Oxygen treatment of novel coronavirus (COVID-19) respiratory failure. Medical Gas Research. 2020; 10: 61-62. http://www.medgasres.com/article.asp?issn=2045-9912;year=2020;volume=10;issue=2;spage=62;epage=62;aulast=Harch
-
Naval Specialty Medical Center Program Team. Demonstration Report on Inclusion of hyperbaric oxygen therapy treatment of Covid-19 Severe Cases. https://www.ihause.org/Hyperbaric_oxygen_therapy_in_the_treatment_ofCOVID-19_Severe_Cases.pdf
-
Antonio De Maioand Lawrence E. Hightower. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Cell Stress Chaperones. 2020 May 18 : 1-4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232923/#CR31
-
Jacques Bessereau, Jerome Aboab, Thomas Hullin, Anne Huon-Cessereau, Jean-Luc Bourgeois, Pierre-Marie Brun, Sylvie Chevret, Djillali Annane. Safety of Hyperbaric Oxygen Therapy in Mechanically Ventilated Patients. 2017;68(1):46-51. https://pubmed.ncbi.nlm.nih.gov/28357836/
-
International Hyperbarics Association. (2020). COVID-19 & Hyperbarics [Brochure]. International Hyperbarics Association.